134 related articles for article (PubMed ID: 36870016)
1. Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study.
Ding X; Yang X; Hao Q; Xu F; Yu X; Rao L; Yuan C; Tian S
J Endocrinol Invest; 2023 Sep; 46(9):1881-1889. PubMed ID: 36870016
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis.
Wang J; Zhang C; Xiang Y; Han B; Cheng Y; Tong Y; Yan D
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12703-12711. PubMed ID: 37452852
[TBL] [Abstract][Full Text] [Related]
4. Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis.
Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
Front Oncol; 2021; 11():713637. PubMed ID: 34497765
[TBL] [Abstract][Full Text] [Related]
5. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program.
Sun YC; Zhao ZD; Yao N; Jiao YW; Zhang JW; Fu Y; Shi WH
BMC Gastroenterol; 2023 Oct; 23(1):354. PubMed ID: 37828423
[TBL] [Abstract][Full Text] [Related]
7. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
[TBL] [Abstract][Full Text] [Related]
8. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.
Ding X; Tian S; Hu J; Wang G; Yu X; Fu D; Yuan Y; Wang L; Wang Z
Int J Colorectal Dis; 2021 Sep; 36(9):1915-1927. PubMed ID: 34061225
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
10. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
11. A Novel Overall Survival Nomogram Prediction of Secondary Primary Malignancies after Hypopharyngeal Cancer: A Population-Based Study.
Wan M; Zhao D; Sun Y; Wang W
J Oncol; 2022; 2022():4681794. PubMed ID: 35528241
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis.
Ding Q; Wang K; Li Y; Peng P; Zhang D; Chang D; Wang W; Ren L; Tang F; Li Z
Am J Clin Oncol; 2023 Jul; 46(7):284-292. PubMed ID: 37145881
[TBL] [Abstract][Full Text] [Related]
14. Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors.
Wang Z; Liu Q
Int J Colorectal Dis; 2023 Feb; 38(1):37. PubMed ID: 36781493
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic model to predict the prognosis of patients with colorectal gastrointestinal stromal tumor: A large international population-based cohort study.
Li Y; Zhang Y; Fu Y; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Wang J; Fan D; Hong L
Front Oncol; 2022; 12():1004662. PubMed ID: 36408151
[TBL] [Abstract][Full Text] [Related]
16. Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.
Ding X; Yang X; Wu D; Huang Y; Dai Y; Li J; Chang W; Chi M; Tian S
Int J Colorectal Dis; 2022 Jun; 37(6):1309-1319. PubMed ID: 35524790
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
Li R; Zhang Y; Ma B; Tan K; Lynn HS; Wu Z
Ann Transl Med; 2021 Feb; 9(3):239. PubMed ID: 33708866
[TBL] [Abstract][Full Text] [Related]
18. A novel risk prediction nomogram for early death in patients with resected synchronous multiple primary colorectal cancer based on the SEER database.
Zhang X; Zhao L; Hu Y; Deng K; Ren W
Int J Colorectal Dis; 2023 May; 38(1):130. PubMed ID: 37191907
[TBL] [Abstract][Full Text] [Related]
19. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
[TBL] [Abstract][Full Text] [Related]
20. Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram.
Zhou S; Jiang S; Chen W; Yin H; Dong L; Zhao H; Han S; He X
Front Oncol; 2021; 11():654439. PubMed ID: 34350109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
